| Eastern Utah Eye Physicians Inc | |
| 200 N Fairgrounds Rd, Ste 2, Price, Utah 84501 | |
| (435) 637-8689 |
| Name | Eastern Utah Eye Physicians Inc |
|---|---|
| Organization Name | Eastern Utah Eye Physicians |
| Location | 200 N Fairgrounds Rd, Ste 2, Price, Utah 84501 |
| Type | Supplier |
| Phone | (435) 637-8689 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Smoking bans are effective at reducing the risk of heart attacks and heart disease associated with exposure to secondhand smoke, says a new report from the Institute of Medicine. The report also confirms there is sufficient evidence that breathing secondhand smoke boosts nonsmokers' risk for heart problems, adding that indirect evidence indicating that even relatively brief exposures could lead to a heart attack is compelling.
Ever worried that all the information you've crammed in during a study session might not stay in your memory? The answer might be going for a run, according to a new study published in Cognitive Systems Research.
The Departments of Health and Human Services and Treasury today took the next steps to establish Affordable Insurance Exchanges - one-stop marketplaces where consumers can choose a private health insurance plan that fits their health needs and have the same kind of insurance choices as members of Congress.
Three prominent philanthropic organizations – The Angel Fund, The ALS Therapy Alliance and Project ALS - dedicated to finding a treatment for amyotrophic lateral sclerosis (ALS) have financed a new collaboration between one of the world's leading ALS researchers and RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi).
Pluristem Therapeutics Inc. today announced that it has entered into definitive agreements with selected investors to sell restricted common stock and warrants for aggregate gross proceeds of approximately $2.7 million. The offering includes 2,420,293 shares of common stock, warrants to purchase 726,088 shares of common stock at an exercise price of $1.25 per share and warrants to purchase 726,088 shares of common stock at an exercise price of $1.40 per share.
› Verified 8 days ago
News Archive
Smoking bans are effective at reducing the risk of heart attacks and heart disease associated with exposure to secondhand smoke, says a new report from the Institute of Medicine. The report also confirms there is sufficient evidence that breathing secondhand smoke boosts nonsmokers' risk for heart problems, adding that indirect evidence indicating that even relatively brief exposures could lead to a heart attack is compelling.
Ever worried that all the information you've crammed in during a study session might not stay in your memory? The answer might be going for a run, according to a new study published in Cognitive Systems Research.
The Departments of Health and Human Services and Treasury today took the next steps to establish Affordable Insurance Exchanges - one-stop marketplaces where consumers can choose a private health insurance plan that fits their health needs and have the same kind of insurance choices as members of Congress.
Three prominent philanthropic organizations – The Angel Fund, The ALS Therapy Alliance and Project ALS - dedicated to finding a treatment for amyotrophic lateral sclerosis (ALS) have financed a new collaboration between one of the world's leading ALS researchers and RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi).
Pluristem Therapeutics Inc. today announced that it has entered into definitive agreements with selected investors to sell restricted common stock and warrants for aggregate gross proceeds of approximately $2.7 million. The offering includes 2,420,293 shares of common stock, warrants to purchase 726,088 shares of common stock at an exercise price of $1.25 per share and warrants to purchase 726,088 shares of common stock at an exercise price of $1.40 per share.
› Verified 8 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 60s 700 E 1, Price, Utah 84501 Phone: (435) 637-9500 | |
Eastern Utah Eye Physicians Inc Type: Medicare Supplier Location: 200 N Fairgrounds Rd, Price, Utah 84501 Phone: (435) 637-8689 | |
Lincare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 268 S Highway 55, Price, Utah 84501 Phone: (435) 637-3511 | |
Smiths Pharmacy #48 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1075 E Main St, Price, Utah 84501 Phone: (435) 637-0840 | |
Walmart Pharmacy 10-1573 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 255 S Highway 55, Price, Utah 84501 Phone: (435) 637-6974 |